We deliver safe and effective
assessments of the liver.
VelacurTM is an accurate, accessible and affordable solution for quantifying liver stiffness and attenuation:
*Based on information submitted in the marketing application.
The procedure is quick, comfortable and non-invasive.
The activation, ultrasound scan and readout can be performed during a standard medical appointment.
Sonic Incytes offers an Early Access Program designed specifically for investigator initiated studies to evaluate the performance and utility of VelacurTM in assessing liver stiffness and attenuation as part of clinical research in chronic liver disease.
If interested in the Early Access Program, please contact us.
We’re proud to collaborate with key centers of clinical excellence in chronic liver disease in North America to evaluate our solution.
Data presented here is investigational only.